OTC Private Labeler RIJ Pharmaceutical Must 'Fully Remediate' Water System

FDA asks RIJ Pharmaceutical, which recalled a dozen products last year, to provide plans for developing a solid water system design and mixing process. It warns private label manufacturer about contaminated, "‘super-potency" OTC drugs that resulted from GMP violations.

Warning Rubber Stamp

More from Marketing & Advertising

More from Business